Your browser doesn't support javascript.
loading
Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden.
Pincez, Thomas; Fernandes, Helder; Leblanc, Thierry; Michel, Gérard; Barlogis, Vincent; Bertrand, Yves; Neven, Bénédicte; Chahla, Wadih Abou; Pasquet, Marlène; Guitton, Corinne; Marie-Cardine, Aude; Pellier, Isabelle; Armari-Alla, Corinne; Benadiba, Joy; Blouin, Pascale; Jeziorski, Eric; Millot, Frédéric; Paillard, Catherine; Thomas, Caroline; Cheikh, Nathalie; Bayart, Sophie; Fouyssac, Fanny; Piguet, Christophe; Deparis, Marianna; Briandet, Claire; Dore, Eric; Picard, Capucine; Rieux-Laucat, Frédéric; Landman-Parker, Judith; Leverger, Guy; Aladjidi, Nathalie.
Afiliação
  • Pincez T; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE), Bordeaux, France; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Department of Pediatrics, Sainte-Justine University Hospital, Université de Montréal, Montréal, Québec.
  • Fernandes H; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE), Bordeaux, France; Pediatric Oncology Hematology Unit, University Hospital, Plurithématique CIC (CICP), Centre d'Investigation Clinique (CIC) 1401, INSERM Bordeaux.
  • Leblanc T; Pediatric Hematology Unit, Robert Debré University Hospital, AP-HP, Paris.
  • Michel G; Department of Pediatric Hematology, La Timone Hospital, Marseille University Hospital, Marseille.
  • Barlogis V; Department of Pediatric Hematology, La Timone Hospital, Marseille University Hospital, Marseille.
  • Bertrand Y; Institute of Pediatric Hematology and Oncology, Lyon University Hospital, Lyon.
  • Neven B; Pediatric Immuno-Hematology and Rheumatology Department, Necker-Enfants Malades University Hospital, AP-HP, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Paris, France; Imagine Institute, UMR 1163 INSERM and Paris University, Paris.
  • Chahla WA; Department of Pediatric Hematology, Jeanne de Flandre Hospital, Lille University Hospital, Lille.
  • Pasquet M; Pediatric Oncology Immunology Hematology Unit, Children's University Hospital, Toulouse.
  • Guitton C; Department of Pediatrics, Bicêtre University Hospital, AP-HP, Le Kremlin-Bicêtre.
  • Marie-Cardine A; Department of Pediatric Hematology and Oncology, Rouen University Hospital, Rouen.
  • Pellier I; Pediatric Unit, Angers University Hospital, Angers.
  • Armari-Alla C; Pediatric Oncology Hematology Unit, Grenoble University Hospital, Grenoble.
  • Benadiba J; Department of Hemato-Oncology Pediatric, Nice University Hospital, Nice.
  • Blouin P; Department of Pediatric Hematology-Oncology, Clocheville Hospital, Tours University Hospital, Tours.
  • Jeziorski E; Pediatric Oncology Hematology Unit, Arnaud de Villeneuve University Hospital, Montpellier.
  • Millot F; Department of Pediatric Hematology, Poitiers University Hospital, Poitiers.
  • Paillard C; Department of Pediatric Hematology and Oncology, Hautepierre University Hospital, Strasbourg.
  • Thomas C; Pediatric Hematology Unit, Nantes University Hospital, Nantes.
  • Cheikh N; Department of Pediatric Hematology-Oncology, Besanc_on University Hospital, Besanc_on.
  • Bayart S; Pediatric Hematology Unit, Rennes University Hospital, Rennes.
  • Fouyssac F; Pediatric Hematology Unit, Nancy University Hospital, Nancy.
  • Piguet C; Pediatric Oncology Hematology Unit, Limoges University Hospital, Limoges.
  • Deparis M; Pediatric Oncology-Hematology Unit Department, Caen University Hospital, Caen.
  • Briandet C; Department of Pediatrics, Dijon University Hospital, Dijon.
  • Dore E; Pediatric Unit, Clermont-Ferrand University Hospital, Clermont-Ferrand.
  • Picard C; Imagine Institute, UMR 1163 INSERM and Paris University, Paris, France; Study Center for Primary Immunodeficiencies, Necker-Enfants Malades University Hospital, AP-HP, Paris.
  • Rieux-Laucat F; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Paris, France; Imagine Institute, UMR 1163 INSERM and Paris University, Paris.
  • Landman-Parker J; Pediatric Oncology Immunology Hematology Unit, Armand-Trousseau University Hospital, AP-HP, Paris.
  • Leverger G; Pediatric Oncology Immunology Hematology Unit, Armand-Trousseau University Hospital, AP-HP, Paris.
  • Aladjidi N; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE), Bordeaux, France; Pediatric Oncology Hematology Unit, University Hospital, Plurithématique CIC (CICP), Centre d'Investigation Clinique (CIC) 1401, INSERM Bordeaux. nathalie.aladjidi@chu-bordeaux.fr.
Haematologica ; 107(2): 457-466, 2022 02 01.
Article em En | MEDLINE | ID: mdl-33440924
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anemia Hemolítica Autoimune Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anemia Hemolítica Autoimune Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article